|
⚲
|
| Keyboard |
| HealthCor Partners Management LP
✚
|
|
|---|---|
| CRD # | 160399 |
| SEC # | 801-74191 |
| CIK # | 0001519462, 0001519456, 0000151946 |
| AUM | 214.1 M (2026-05-05) |
| Employees | 3 (67% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-622-7726 |
| Address | |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
FEES AND COMPENSATION
The Adviser’s current compensation structure for the Funds is summarized as follows:
• Investment Management Fees: The Adviser receives an asset-based fee from each of
the Funds equal to:
1. During the Investment Period (as defined below), 2.0% per annum of the capital
commitments for each Fund.
2. Following the expiration of the Investment Period until the end of the term of
the Funds, including any extensions, 2.0% per annum of capital commitments
that have been (i) invested in portfolio companies that have not been realized or
written off, and (ii) reserved for follow-on investments. With respect to Fund I
only, the Management Fee was reduced from 2.0% per annum to 1% per annum
effective January 1, 2018, and further reduced from 1% per annum to zero
effective January 1, 2019. With respect to Fund II only, the Management Fee
was reduced from 2.0% per annum to 1% per annum effective July 1, 2019, and
further reduced from 1% per annum to zero effective January 1, 2020.
Management Fees are paid quarterly in advance through a drawdown of capital from
investors.
The Management Fee may be reduced, but not below zero, by the sum of:
1. The amount of any excess organizational expenses since the preceding payment
date,
2. The amount of any fee income received by the Adviser since the preceding
payment date, and
3. The amount of any incentive capital contributions made since the previous
payment date.
• Carried Interest Allocation: An affiliate of the Adviser receives performance-based
compensation from each of the Funds in connection with the performance of its duties
equal to 20% of the profits generated from the disposition of portfolio companies (after
deduction of certain fees, including the Management Fee, and other expenses) and
achievement of a preferred annual return to investors equal to 8% of capital, invested
in such portfolio company, plus the allocated expenses (including management fee),
compounded annually.
In 2023 the SPV invested additional capital in its portfolio investment (the “Series F
investment”) and will receive Management Fee equal to 1% of capital invested by non-affiliated
members in the Series F investment. An affiliate of the Advisor will receive performance-based
compensation equal to 10% of the profits generated from the capital invested the Series F
investment by non-affiliated members.
In 2025 the SPV invested additional capital in its portfolio investment (the “Convertible Note
investment”) and will receive Management Fee equal to 1% of capital invested by non-affiliated
members in the Convertible Note investment. An affiliate of the Advisor will receive
performance-based compensation equal to 10% of the profits generated from the capital invested
in the Convertible Note investment by non-affiliated members.
The investment period (the “Investment Period”) is the period of time during which the
Adviser may make investments in new and existing portfolio companies. The Investment
Period is typically four years, and will be specified in the offering documents for each specific
Fund. For a specific period of time following the Investment Period, typically three years, the
Adviser is generally limited to making follow-on investments in portfolio companies that exist
at the end of the Investment Period. Such follow-on investments are limited to a certain
percentage of capital commitments that the Adviser is permitted to reserve in accordance with
each Fund’s respective offering documents. The Investment Period and the period for follow-
on investments in portfolio companies for each of the Funds has closed.
Investors do not have the ability to choose to be billed directly for such amounts, which are
non-negotiable. The Adviser may waive, reduce or otherwise modify the Management Fee
and/or the Carried Interest Allocation for any investor in a Fund.
The Adviser and some of its personnel may from time to time purchase secondary interests in
the Funds. The Adviser and its personnel are not typically charged a Management Fee or a
Carried Interest Allocation, as defined below, by the Funds on their investments in the Funds.
Additionally, the Adviser and its personnel do pay Management Fees and Carried Interest on
any Secondary Fund interests purchased.
The Adviser will pay all normal operating expenses incidental to the provision of the day-to-
day administrative services to the Funds, including its own overhead and expenses incurred in
the preliminary investigation of investments that are not actively pursued. Each Fund will pay
all costs, expenses and liabilities in connection with its operations, including: fees, costs and
expenses related to the purchase, holding and sale of portfolio investments (to the extent not
reimbursed); taxes; fees and expenses of accountants and counsel, including expenses
associated with the preparation of financial statements, tax returns, Schedule K-1, auditing,
banking and consulting; costs and expenses of the advisory committee and the annual meeting;
the cost of directors and officers and errors and omissions insurance premiums; legal (including
litigation) fees and expenses; costs, expenses and liabilities resulting from such Fund’s
indemnification obligations and other extraordinary expenses; the costs of winding up and
liquidating the Funds. To the extent possible, third party costs will be charged to portfolio
companies.
Each Fund bears all legal, travel and other reasonable expenses (including printing and filing
fees) incurred in the formation of such Fund and the offering of interests in such Fund up to
... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
TYPES OF CLIENTS The clients to whom the Adviser generally provides investment advice are private investment funds offered to investors on a private placement basis, as described above. Details concerning applicable suitability criteria for investors in the Funds are set forth in the Funds’ offering memoranda and subscription documents. Although the Adviser has the authority to accept and has on occasion accepted subscriptions for any lesser amount, the minimum investment in the Funds is generally $5,000,000. Each investor is required to meet certain suitability qualifications, such as being a “qualified purchaser” as defined in the Investment Company Act of 1940, as amended. In addition, there are prohibitions on withdrawals from the Funds and restrictions on transfers of interests in the Funds. Because of these prohibitions and restrictions, an investment in the Funds is a continuing commitment to invest the amount of capital subscribed for by an investor, is an illiquid investment, and involves a high degree of risk. A subscription for limited partner interests in the Funds should be considered only by persons financially able to maintain their investment and who can accept a loss of all of their investment. |
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | Hcpciv 1 LLC | 2016-03-30 | 134.8 M | |
| Other | HealthCor Paradigm Blocker Company One Inc | 2012-02-15 | ||
| PE | HealthCor Partners Fund II LP | [2012-02-15] | 100.8 M | 40.2 M |
| Filed 2014-02-28 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | HealthCor Partners Fund LP | [2012-02-15] | 39.1 M | |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 214.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 214.1 |
| By Discretionary | ||
| Discretionary | 3 | 214.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 214.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 11.5 | |
| United States Persons | 202.6 | |
| Total | 3 | 214.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Christine Clarke | Executive Officer | 56 | 5 | |
| Steven Musumeci | Executive Officer | 22 | 5 | |
| Arthur Cohen | Executive Officer | 57 | 4 | |
| Joseph Healey | Executive Officer | 54 | 4 | |
| Anabelle Gray | Executive Officer | 41 | 3 | |
| Jeffrey Lightcap | Executive Officer | 41 | 3 | |
| John Coghlin | Executive Officer | 12 | 3 | |
| Advisors Mercury Capital | Promoter | 2 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001519456] | |
| 4 | [0001519456] | |
| 13F-HR | [0001519462] | |
| 3 | [0001519462] | |
| 4 | [0001519462] | |
| SC 13D | [0001519462] | |
| SC 13G | [0001519462] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| HealthCor Partners Management LP | Heartflow Inc | [2026-03-31] |
| HealthCor Partners Management LP | Heartflow Inc | [2025-11-24] |
| HealthCor Partners Management LP | Reshape Lifesciences Inc | [2018-06-05] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.2B |
| Serves | Institutional |
| Fund Types | Private Equity |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Heartflow Inc HTFL
COMMON STOCK
|
2026-03-24 | Other | 4,615,542 | ||
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-05-24 | Conversion | 93,485,000 | $0.10 | 9,348,500 |
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-05-24 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-05-24 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-05-24 | Conversion | 86,515,000 | $0.10 | 8,651,500 |
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-03-30 | Conversion | 6,000,000 | $0.10 | 600,000 |
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-03-30 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-03-30 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-03-30 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-03-30 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-03-30 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-03-30 | Conversion | 86,515,000 | $0.10 | 8,651,500 |
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2023 · derivative
|
2023-03-30 | Conversion | $0.00 | ||
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-03-30 | Conversion | 93,485,000 | $0.10 | 9,348,500 |
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-03-30 | Conversion | 6,500,000 | $0.10 | 650,000 |
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-03-30 | Conversion | 7,000,000 | $0.10 | 700,000 |
|
CareView Communications Inc CRVW.OB
Common Stock
|
2023-03-30 | Conversion | 8,141,660 | $0.10 | 814,166 |
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2025 · derivative
|
2022-12-30 | Disposed to issuer | |||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2029 · derivative
|
2022-12-30 | Disposed to issuer | |||
|
CareView Communications Inc CRVW.OB
Senior Secured Convertible Note due 2028 · derivative
|
2022-12-30 | Disposed to issuer | |||
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Tucker's Farm Management Company I LP
✚
|
MA | 217.0 M |
|
ICP Group Investment Manager LLC
✚
|
TX | 215.9 M |
|
OZE Capital LLC
✚
|
NJ | 213.7 M |
|
Long Point Capital Inc
✚
|
NY | 213.5 M |
|
Lake Pacific Management Company LLC
✚
|
TX | 213.2 M |
|
GEN Cap America Inc
✚
|
TN | 212.6 M |
|
Excolere Equity Partners LLC
✚
|
CA | 212.2 M |
|
JMC Management LLC
✚
|
MA | 211.9 M |
|
Skylark Private Equity Partners LP
✚
|
TX | 211.4 M |
|
Sentinel Global LP
✚
|
CA | 210.3 M |